PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1364703
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1364703
T-Cell Therapy Market, By Therapy Type, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
T-Cell Therapy Market size was valued at USD 2,708.6 Million in 2022, expanding at a CAGR of 34.9% from 2023 to 2030.
T-cell therapy is a form of immunotherapy in which T-cells, a type of white blood cell, are used to treat specific disorders, most notably cancer. There are two main types of T-cell transfer therapy tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy. T-cell transfer therapy was initially investigated for the treatment of metastatic melanoma since melanomas frequently cause a robust immune response and have a high number of TILs. TIL treatment has been shown to be successful in some cases of melanoma and has achieved encouraging results in other cancers such as cervical squamous cell carcinoma and cholangiocarcinoma. However, T-cell therapy is a key advancement in cancer treatment. Conversely, like many medicines, it comes with both enormous promise and significant challenges. There is continuing research to increase the efficacy, safety, and accessibility of these medicines.
T-Cell Therapy Market- Market Dynamics
The rising focus on Developing new therapies for the treatment of diseases is expected to drive the growth of the T-cell therapy market.
As the global prevalence of diseases, particularly cancer, rises, there is an urgent requirement for more effective and tailored therapies. According to the National Cancer Institute, in 2023, roughly 2.0 million people will be diagnosed with cancer in the United States. An estimated 297,790 women and 2,800 men will be diagnosed with breast cancer, which makes it the most common cancer diagnosis. T-cell treatments are emerging as a viable treatment option, particularly for individuals suffering from resistant or recurrent diseases. Given the potential of T-cell treatments, enormous investment has been made in research and development. Furthermore, advancing research on novel biotherapies and increasing the supply and safety of biologics are the factors that are expected to provide growth opportunities for the T-cell therapy market. However, severe life-threatening toxicities, modest anti-tumor activity, antigen escape, restricted trafficking, and limited tumor infiltration are the factors that restrict the growth of the market.
T-Cell Therapy Market- Key Insights
- As per the analysis shared by our research analyst, the global T-Cell Therapy market is estimated to grow annually at a CAGR of around 34.9% over the forecast period (2023-2030)
- The T-cell therapy industry is expected to grow at a rapid pace due to the rising cancer burden and increased research and development to create T-cell therapy.
- Based on Therapy type segmentation, CAR T-cell Therapy was predicted to show maximum market share in the year 2022
- Based on Indication segmentation, Hematologic Malignancies was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
T-Cell Therapy Market- Segmentation Analysis:
The Global T-Cell Therapy Market is segmented on the basis of Therapy Type, Indication, and Region.
The market is divided into three categories based on Therapy type: CAR T-cell Therapy, Cell Receptor (TCR)-based, and Tumor Infiltrating Lymphocytes (TIL)-based. CAR T-cell Therapy segment is expected to dominate the market growth. CAR-T therapy is a type of T-cell therapy in which T-cells are genetically engineered to express a receptor (the CAR) that can specifically target cancer cells.
The market is divided into two categories based on Indication: Hematologic Malignancies, Solid Tumors, and Others. Hematologic Malignancies dominate the market growth. CAR-T-cell immunotherapy is widely recognized as an important treatment option for patients suffering from hematological malignancies such as acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL).
T-Cell Therapy Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to the increasing number of pharmaceutical companies focusing on developing adoptive therapies, North America, particularly the United States, is host to a myriad of biotech startups, prestigious research institutions, and some of the world's largest pharmaceutical companies. These organizations actively invest in and push the margins of novel therapeutics, such as adoptive T-cell therapy. For example, Fate Therapeutics, Inc, a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, presented preclinical data of several novel strategies designed to enable the administration of off-the-shelf cell-based cancer immunotherapies without conditioning chemotherapy at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. Furthermore, Europe and Asia Pacific are expected to propel significant growth in T-cell therapy Market, due to the Growing Product Approvals Associated with T-cell therapies like Chimeric antigen receptor (CAR)-T cell therapy and T Cell Receptor (TCR)-based and Tumor Infiltrating Lymphocytes (TIL)-based.
T-Cell Therapy Market- Competitive Landscape:
Several new market players are driving innovation in the field of T-cell therapy. Some are concentrating on next-generation CAR-T therapy, while others are investigating alternate cell types, safer designs, or cost-cutting strategies. Also, the robust development of new CAR-T therapies is characterized by the active use of intellectual property rights by firms, as well as substantial R&D investments. Manufacturers exhibit CAR-T technologies' patent and clinical landscape, covering the current clinical trial environment, cutting-edge CAR-related inventions, the main actors, and how they interact with one another to generate new technologies. Furthermore, T-cell treatments were initially more focused in regions such as North America and parts of Europe. Regulatory approvals in Asia-Pacific, Latin America, and the Middle East can open up large new markets, raising demand as corporations expand their reach.
Recent Developments:
In October 2019, Merck, a leading science and technology company, nowadays announced it had acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL T-CELL THERAPY MARKET KEY PLAYERS
- Novartis AG
- Merck KGaA
- Gilead Sciences Inc.
- TCR2 Therapeutics Inc
- Bluebird Bio Inc.
- Sorrento Therapeutics
- Fate Therapeutics
- Pfizer Inc.
- Amgen
- Celgene Corporation
GLOBAL T-CELL THERAPY MARKET, BY THERAPY TYPE
- CAR T-cell Therapy
- T Cell Receptor (TCR)-based
- Tumor Infiltrating Lymphocytes (TIL)-based
GLOBAL T-CELL THERAPY MARKET, BY INDICATION
- Hematologic Malignancies
- Solid Tumors
- Others
GLOBAL T-CELL THERAPY MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. T-Cell Therapy Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. T-Cell Therapy Market Snippet by Therapy Type
- 2.1.2. T-Cell Therapy Market Snippet by Indication
- 2.1.3. T-Cell Therapy Market Snippet by Country
- 2.1.4. T-Cell Therapy Market Snippet by Region
- 2.2. Competitive Insights
3. T-Cell Therapy Key Market Trends
- 3.1. T-Cell Therapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. T-Cell Therapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. T-Cell Therapy Market Opportunities
- 3.4. T-Cell Therapy Market Future Trends
4. T-Cell Therapy Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. T-Cell Therapy Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. T-Cell Therapy Market Landscape
- 6.1. T-Cell Therapy Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. T-Cell Therapy Market - By Therapy Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
- 7.1.2. CAR T-cell Therapy
- 7.1.3. T Cell Receptor (TCR)-based
- 7.1.4. Tumor Infiltrating Lymphocytes (TIL)-based
8. T-Cell Therapy Market - By Indication
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
- 8.1.2. Hematologic Malignancies
- 8.1.3. Solid Tumors
- 8.1.4. Others
9. T-Cell Therapy Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. T-Cell Therapy Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. T-Cell Therapy Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. T-Cell Therapy Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. T-Cell Therapy Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. T-Cell Therapy Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- T-Cell Therapy Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Novartis AG
- 10.2.2. Merck KGaA
- 10.2.3. Gilead Sciences Inc.
- 10.2.4. TCR2 Therapeutics Inc
- 10.2.5. Bluebird Bio Inc.
- 10.2.6. Sorrento Therapeutics
- 10.2.7. Fate Therapeutics
- 10.2.8. Pfizer Inc.
- 10.2.9. Amgen
- 10.2.10. Celgene Corporation
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE T-Cell Therapy Market: Therapy Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Therapy Type
- TABLE Global T-Cell Therapy Market, by Therapy Type 2018-2030 (USD Million)
- TABLE T-Cell Therapy Market: Indication Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Indication
- TABLE Global T-Cell Therapy Market, by Indication 2018-2030 (USD Million)
- TABLE T-Cell Therapy Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global T-Cell Therapy Market, by Region 2018-2030 (USD Million)
- TABLE North America T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
- TABLE North America T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
- TABLE North America T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
- TABLE Europe T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
- TABLE Europe T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
- TABLE Europe T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
- TABLE Asia Pacific T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
- TABLE Asia Pacific T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
- TABLE Latin America T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
- TABLE Latin America T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
- TABLE Middle East and Africa T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
